¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25
±³À°ÀÏÀÚ : 2024-05-25
±³À°Àå¼Ò : Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°­´ç

±³À°ÁÖÁ¦ : The 1st International Symposium on Precision Oncology in Breast Cancer

ÁÖÃÖ±â°ü : Ä¥°î°æºÏ´ëÇб³º´¿ø
´ã´çÀÚ : °­º´ÁÖ
¿¬¶ôó : 053-200-7281  

À̸ÞÀÏ : knuh_bts@naver.com

±³À°Á¾·ù : ³»°ú, ¿Ü°ú

Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 10,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 09:30~09:40 Opening remark ( )

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 09:30~10:00 Aquaporin water channels as regulators of cell-cell adhesion proteins Tae-Hwan Kwon(Dean. School of Medicine Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 10:10~10:40 Multimodal chemo-, gene, and immunotherapy for cancer Young Jik Kwon(University of California, Irvine)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 10:40~11:10 Next-generation diagnostic technology for breast cancer detection and treatment monitoring Hyungsoon Im(Harvard Medical School)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 11:10~11:40 Towards the precision oncology through innovative clinical trials and translational efforts Young Kwang Chae(Northwestern University)

Åä·Ð 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 11:40~11:50 Q & A ()

½Ä»ç 05¿ù 25ÀÏ 11:50~13:00 Lunch ()

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 13:00~13:20 Prediction of neoadjuvant chemotherapy response using ctDNA in HER2+ breast cancer Soo Jung Lee(Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 13:20~13:40 Deep Learning-based Radiogenomic Prediction Study for Combined Breast MRI and OncotypeDX Recurrence Scores in Breast Cancer: A Fully-Automated Framework Jeeyeon Lee(Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 13:40~14:00 Testing for ESR1 mutations in the ctDNA from ER+/HER2- advanced or metastatic breast cancer Sung-hye Hong(Gencurix Inc.)

Åä·Ð 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 14:00~14:10 Q & A ()

ÈÞ½Ä 05¿ù 25ÀÏ 14:10~14:20 Coffee Break ()

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 14:20~14:35 Prediction of pCR in hormone positive breast cancer In Hee Lee(Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 14:35~14:50 Molecular tuned extracellular blebs for improved vaccination and intracellular delivery Olivia Ritchie(University of California, Irvine)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 14:50~15:05 Multimodal gene delivery platform for versatile combination cancer therapies Rebecca Lee(University of California, Irvine)

Åä·Ð 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 15:05~15:15 Q & A ()

ÈÞ½Ä 05¿ù 25ÀÏ 15:15~15:25 Coffee Break ()

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 15:25~15:40 LncRNA in breast cancer: SOX2OT and IGF2-AS in tamoxifen-resistant cell lines Byeongju Kang(Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 15:40~15:55 Transplant-Oncology, a new era of innovation for the select cancer patients; DREAM registration study Chan Mi Jung(Northwestern University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 15:55~16:10 Development of Chimeric Antigen Receptor (CAR) Based NK Cell Immunotherapy Against Solid Tumor Jee Young Chung(CHA Advanced Research Institute)

Åä·Ð 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 16:10~16:20 Q & A ()

±âŸ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 16:20~16:30 Closing remark ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25
´ÙÀ½±Û (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
272 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-17 0 449 2018-07-28
271 °æ±â Á¦ 1ȸ ¾ÆÁִ뺴¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-16 0 2,166 2018-07-28
270 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Á¦53Â÷ ¾Ë·¹¸£±â ±³À°°­Á : 2018-09-16 0 607 2018-07-28
269 ¼­¿ï 2018³â Á¦3ȸ »ï¼º¼­¿ïº´¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-09-16 0 951 2018-07-28
268 ´ë±¸ 2018³âµµ ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ Çмú´ëȸ : 2018-09-16 0 851 2018-07-28
267 ¼­¿ï ½ÉÀå´ë»çÁõÈıº¿¬±¸È¸ 2018 Ãß°è½ÉÆ÷Áö¾ö : 2018-09-15 0 692 2018-07-28
266 ¼­¿ï °æÈñ´ëÇб³º´¿ø µ¿¹®Áý´ãȸ_°íȲÀ̺ñÀÎÈÄ°ú ¿¬±¸È¸ ¼¼¹Ì³ª : 2018-09-15 0 1,448 2018-07-28
265 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : °æ°è¼± ÀΰÝÀå¾Ö : 2018-09-15 0 1,232 2018-07-28
264 ¼­¿ï ¼­¿ï¼º¸ðº´¿ø ½ÅÀåÀÌ½Ä 3,000·Ê ±â³ä ´ëÇÑÀ̽ÄÇÐȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2018-09-15 0 672 2018-07-28
263 °­¿ø ´ëÇÑ°ñÀýÇÐȸ Á¦2ȸ ÇÏÁö°ñÀý ½ÉÆ÷Áö¾ö : 2018-09-15 0 646 2018-07-28
262 Àü³² ¸ñÆ÷½ÃÀÇ»çȸ Çмú´ëȸ(°æµ¿¸Æ¼Õ»ó,°áÇÙ) : 2018-09-15 0 2,721 2018-07-28
261 ¼­¿ï °í·Á´ëÇб³ ½Å°æ°úÇб³½Ç ½ÉÆ÷Áö¿ò : 2018-09-15 0 1,978 2018-07-28
260 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÄÚºí·¹ÀÌÅ͸¦ ÀÌ¿ëÇÑ ´Ù¾çÇÑ ºñ°ú ¼ö¼úµé : 2018-09-15 0 773 2018-07-28
259 °æ±â Á¦6ȸ ÇѸ²´ëÇб³¼º½Éº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ½ÉÆ÷Áö¿ò : 2018-09-15 0 909 2018-07-28
258 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-14 0 655 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷